Technology | PACS | January 22, 2018

QualiTest Releases Virtual Radiology Environment 2.0 PACS Testing Solution

Comprehensive DICOM and HL7 testing solution offers enhanced crowd testing and smarter artificial intelligence

January 22, 2018 — QualiTest Group recently announced its improved Virtual Radiology Environment (VRE) testing solution for picture archiving and communication systems (PACS). The offering builds upon the original solution with enhanced crowd testing and artificial intelligence (AI) capabilities, enabling vendors to scale more quickly.

QualiTest’s VRE automation accelerator tests PACS for scalability and reliability, delivering a comprehensive answer for synchronized Digital Imaging and Communications in Medicine (DICOM) and Health Level 7 (HL7) traffic. The VRE solution increases DICOM and HL7 test coverage, reducing efforts and cost by up to 80 percent. Integrating seamlessly with the latest automation tools, the solution supports external scripting and merges fully with all other AI-driven systems.  

As healthcare providers have grown increasingly dependent upon the reliability and scalability of PACS, these systems have become increasingly complex and vendors have witnessed them receive more data than they ever anticipated. However, though features can be verified simply, scalability is challenging to test. QualiTest’s VRE solves this problem by enabling vendors to simulate all the network patterns and data flows that naturally occur in the radiology industry, using its enhanced AI capabilities to generate extensive volumes of data from limited sets of inputs.

QualiTest demonstrated the VRE solution at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago.

For more information: www.qualitestgroup.com

 

Related Content

Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions, and VasoTechnololgy, a subsidiary of the Vaso Corporation, announced an agreement to distribute Candelis' suite of image management PACS solutions and cloud services, including ImageGrid, ImageGrid Mini PACS and ASTRA Cloud.
News | Enterprise Imaging | July 29, 2020
July 29, 2020 — Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions,
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

News | Prostate Cancer | July 28, 2020
July 28, 2020 — A study published in 
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510
News | Artificial Intelligence | July 14, 2020
July 14, 2020 — Lunit, a leading medical AI startup, announced the expansion of its collaboration with...
News | Information Technology | July 14, 2020
July 14, 2020 — The COVID-19 pandemic caused hea
Infervision's newly FDA approved CT lung AI application sets a new standard
News | Artificial Intelligence | July 10, 2020
July 10, 2020 — Infervision announced U.S.
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201